Vibegron

Chemical formula: C₂₆H₂₈N₄O₃  Molecular mass: 444.216 g/mol  PubChem compound: 44472635

Therapeutic indications

Vibegron is indicated for:

Overactive bladder

Population group: only adults (18 years old or older)

Vibegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Vibegron is contraindicated in the following cases:

eGFR <15 mL/min/1.73 m²

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic impairment

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2021: GEMTESA Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈